Dixon's report 30 Oct - re cure for "patent's" with back problems - Kt009. Why wasn't this reported in Bishop's annual report only 4 days earlier - lack of communication or some other reason ?
Re Dixon's exciting new product announcement - the combination of two, old unproven products/ideas has failure written all over it - syringe patent 2006 - Kt009 patent 2007 (syringe only a drawing with a number) - not much of a choice out of the seventy odd products they assessed. I can't see this happening in my lifetime.
- Forums
- ASX - By Stock
- Ann: Technology License and Clinial Development Program Agreement
Dixon's report 30 Oct - re cure for "patent's" with back...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MGZ (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online